IDH1 and central nervous system cancer: In addition to the neoplasms covered in this review, H3K27me3 loss was reported to predict a significantly better prognosis in diffuse IDH-mutant hemispheric gliomas [80], although it appeared to have no prognostic impact in rosette-forming glioneuronal tumors [96].